Public Policy Tipoffs Involving Delaware Newsletter for Saturday May 03, 2025 ( 18 items ) |
Brandywine Students Attend and Speak at Math Conference
MEDIA, Pennsylvania, April 29 -- The Pennsylvania State University Brandywine Campus issued the following news:
* * *
Brandywine students attend and speak at math conference
By Christina Billie
MEDIA, Pa. - Penn State Brandywine students who are members of the Math Club recently attended and spoke at a math conference in Mechanicsburg, Pennsylvania, using the opportunity to expand both their knowledge of the field and their networking skills.
The Spring Meeting of the Eastern Pennsylvania a
more
BREZTRI Met Primary Endpoints in KALOS and LOGOS Phase III Trials in Asthma
WILMINGTON, Delaware, May 3 -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
BREZTRI met primary endpoints in KALOS and LOGOS Phase III trials in asthma
Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca's fixed-dose triple-combination therapy BREZTRI AEROSPHERE (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6ug)) met all primary endpoints, demonstrating a st
more
CAIR Welcomes Charges for 'KKK' Vandalism of Black Church in Delaware, Sentencing for Racist Harassment
WASHINGTON, April 29 [Category: Sociological] -- The Council on American-Islamic Relations posted the following news release:
* * *
CAIR Welcomes Charges for 'KKK' Vandalism of Black Church in Delaware, Sentencing for Racist Harassment
The Council on American-Islamic Relations (CAIR), the nation's largest Muslim civil rights and advocacy organization, today welcomed charges for the racist vandalism of a Black church in Dover, Delaware. CAIR also welcomed the sentencing of a woman for racist h
more
DEA Publishes Bulk Manufacturer Application Notice for Siemens Healthcare Diagnostics Inc.
WASHINGTON, April 27 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration (DEA) has issued a notice regarding an application from Siemens Healthcare Diagnostics Inc. to become a registered bulk manufacturer of a controlled substance. The notice, published in the Federal Register on April 28, 2025, details that Siemens Healthcare Diagnostics Inc., with a facility located in Newark, Delaware 19702-2461, submitted its application on January 15, 2025.
The company is seeking au
more
DuPont Announces Regular Quarterly Dividend on Common Stock
WILMINGTON, Delaware, April 30 -- DuPont issued the following news release:
* * *
DuPont Announces Regular Quarterly Dividend on Common Stock
WILMINGTON, Del., April 29, 2025 - DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of forty-one cents ($0.41) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on June 16, 2025, to holders of record of said stock at the close of business on May 30, 2025.
About D
more
Everytown for Gun Safety and Delaware Chapter of Moms Demand Action Celebrate Governor Matt Meyer's 100th Day in Office With Signing of Executive Order to Create Delaware Office of Gun Violence Prevention and Community Safety
NEW YORK, May 1 [Category: Sociological] -- Everytown for Gun Safety posted the following news release:
* * *
Everytown for Gun Safety and Delaware Chapter of Moms Demand Action Celebrate Governor Matt Meyer's 100th Day in Office With Signing of Executive Order to Create Delaware Office of Gun Violence Prevention and Community Safety
DOVER, De - Today, Everytown for Gun Safety and the Delaware chapters of Moms Demand Action and Students Demand Action, both part of Everytown for Gun Safety's g
more
FDA Releases Public Communication From Natural Food Colors Association Chairman Ganivet
WASHINGTON, April 30 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication on Jan. 21, 2025, from Luc Ganivet, chairman of the Natural Food Colors Association Inc., Dover, Delaware:
* * *
To: Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852
RE: Docket No. FDA 2024-N-3609: Development of an Enhanced Systematic Process for FDA's Post-Market Assessme
more
Hunton Represents U.S. Chamber of Commerce As Amicus in Appeal to Delaware Supreme Court on Musk Compensation
DALLAS, Texas, May 1 -- Hunton Andrews Kurth, a law firm, issued the following news:
* * *
Hunton Represents U.S. Chamber of Commerce As Amicus in Appeal to Delaware Supreme Court on Musk Compensation
Hunton Andrews Kurth LLP has filed an amicus brief on behalf of the U.S. Chamber of Commerce before the Delaware Supreme Court.
The brief supports the position of Tesla, Inc. in its appeal of the Delaware Court of Chancery's judgment rescinding the compensation package for its CEO, Elon Musk.
more
ICYMI: AFP-OH, H.B. 11 Bill Sponsors Champion REINS Legislation on 'Rock N REINS: The Red Tape Roadshow Tour'
ARLINGTON, Virginia, April 30 [Category: Sociological] -- Americans for Prosperity posted the following news release:
* * *
ICYMI: AFP-OH, H.B. 11 Bill Sponsors Champion REINS Legislation on 'Rock N REINS: The Red Tape Roadshow Tour'
#
Apr 30, 2025 by AFP
Lewis Center, OH - Yesterday, Americans for Prosperity - Ohio (AFP-OH) held an event as part of their Rock N REINS: The Red Tape Roadshow Tour featuring House Bill 11 sponsors State Rep. Ron Ferguson (R-Wintersville) and State Rep. Bria
more
In fiery questioning, Senator Coons attacks Trump, DOGE, Senate Republicans for cuts to medical research in Appropriations Hearing
WASHINGTON, April 30 -- Sen. Christopher Coons, D-Delaware, issued the following news release:
* * *
In fiery questioning, Senator Coons attacks Trump, DOGE, Senate Republicans for cuts to medical research in Appropriations Hearing
WASHINGTON - U.S. Senator Chris Coons (D-Del.) took President Trump, Elon Musk and DOGE, and his Republican colleagues to task today for their brutal cuts to medical research that threaten to take away hope from millions of Americans. His remarks came during emotio
more
IRS Releases Public Communication From Corteva Agriscience
WASHINGTON, May 1 -- The U.S. Department of the Treasury Internal Revenue Service has released the following public communication on April 10, 2025, from Corteva Agriscience, Wilmington, Delaware:
* * *
To: U.S. Department of the Treasury
Internal Revenue Service
CC:PA:01: PR (Notice 2025-10)
CC:PA:01:PR (Notice 2025-11)
Room 5203, PO Box 7604
Ben Franklin Station
Washington, DC 20044
Re: Request for Public Comments
Notice 2025-10: Sec.45Z Clean Fuel Production Credit;
Notice 2025-11
more
Ohio Wesleyan University: 'Epic Rebirth'
DELAWARE, Ohio, April 26 -- Ohio Wesleyan University issued the following news release:
* * *
'Epic Rebirth'
Ohio Wesleyan Raises Over $50M in Three Months for Visionary Fine Arts-Infused Library, Launches Ohio's Largest Campus Solar Project
DELAWARE, Ohio - Ohio Wesleyan University has raised a record-breaking $50 million in just three months to fund a visionary, fine arts-infused library - and launched a public-private partnership delivering Ohio's largest onsite campus solar initiative. T
more
Rep. McBride: Cutting Lifeline of Institute of Museum and Library Services
WASHINGTON, May 2 -- Rep. Sarah McBride, D-Delaware, issued the following floor remarks on May 1, 2025 (In this document, the reference to Mr. Speaker refers to the presiding officer of the House at the time of the speech):
* * *
Mr. Speaker, I rise today to condemn this administration's harmful and illegal efforts to gut the Institute of Museum and Library Services.
Let's be clear. This is a direct attack on rural families, veterans, caregivers, and children, including thousands of Delawarea
more
Senator Coons condemns President Trump's disastrous first 100 days in speech on Senate floor
WASHINGTON, April 29 -- Sen. Christopher Coons, D-Delaware, issued the following news release:
* * *
Senator Coons condemns President Trump's disastrous first 100 days in speech on Senate floor
WASHINGTON - U.S. Senator Chris Coons (D-Del.) delivered a floor speech tonight criticizing President Donald Trump's first 100 days in office, describing a period marked by weakened global alliances, harsh cuts to foreign aid, and an overhaul of key federal agencies.
Today marks the 100th day of Pres
more
Senators Coons, Cassidy, colleagues introduce legislation to help Americans better plan for retirement
WASHINGTON, May 1 -- Sen. Christopher Coons, D-Delaware, issued the following news release:
* * *
Senators Coons, Cassidy, colleagues introduce legislation to help Americans better plan for retirement
WASHINGTON - U.S. Senators Chris Coons (D-Del.), Bill Cassidy, M.D. (R-La.), Tim Kaine (D-Va.), and Susan Collins (R-Maine) reintroduced legislation to enhance Americans' retirement security by ensuring they have the information they need to make more informed decisions about when to begin claim
more
Senators Coons, Tillis, colleagues introduce bipartisan, bicameral bill to foster American innovation by modernizing the Patent Trial and Appeal Board
WASHINGTON, May 1 -- Sen. Christopher Coons, D-Delaware, issued the following news release:
* * *
Senators Coons, Tillis, colleagues introduce bipartisan, bicameral bill to foster American innovation by modernizing the Patent Trial and Appeal Board
WASHINGTON - U.S. Senators Chris Coons (D-Del.), Thom Tillis (R-N.C.), Dick Durbin (D-Ill.), and Mazie Hirono (D-Hawaii) reintroduced the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act today. The PREVAIL Ac
more
Senators Coons, Tillis, colleagues introduce bipartisan, bicameral legislation to restore American innovation
WASHINGTON, May 2 -- Sen. Christopher Coons, D-Delaware, issued the following news release:
* * *
Senators Coons, Tillis, colleagues introduce bipartisan, bicameral legislation to restore American innovation
WASHINGTON - U.S. Senators Chris Coons (D-Del.), a member of the Judiciary Committee's Intellectual Property Subcommittee, and Thom Tillis (R-N.C.), Chairman of the Senate Judiciary Subcommittee on Intellectual Property, reintroduced the Patent Eligibility Restoration Act (PERA). This bip
more
Update on CAPItello-280 Phase III Trial of TRUQAP (capivasertib) in Metastatic Castration-Resistant Prostate Cancer
WILMINGTON, Delaware, April 30 -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
Update on CAPItello-280 Phase III trial of TRUQAP (capivasertib) in metastatic castration-resistant prostate cancer
AstraZeneca is discontinuing the CAPItello-280 Phase III trial evaluating the efficacy and safety of TRUQAP (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) compared to docetaxel and ADT with placebo in patients with metastatic c
more
|
Sign up to Receive this newsletter every day via email.